Press release BoxID: 313859 (Cluster Gesundheitswirtschaft Berlin-Brandenburg - HealthCapital)
  • Cluster Gesundheitswirtschaft Berlin-Brandenburg - HealthCapital
  • Fasanenstraße 85
  • 10623 Berlin
  • Contact person
  • Thilo Spahl
  • +49 (30) 3186-2214

3rd Annual European Life Science CEO Forum

(PresseBox) (Berlin, ) Building on the success of last year's event, the 3rd Annual European Life Science CEO Forum, an exclusive and highly transactional forum for investing and partnering in the Biotech and Pharma industry is back at the SIX Swiss Exchange, Zurich. Attended by 300 delegates over a twoday program, the forum will provide you with truly excellent networking opportunities, allowing access to some of the leading players in the industry. More over, the 500 meeting slots available through the online 121 meeting system makes this event a must for companies wishing to meet with their peers, engage with leading investors and forge new partnerships.

Program features:

- Plenary panel sessions covering investment, partnering and M&A, investing in vaccines and an interactive panel session.
- 60 company presentations by public and private, venture funded companies 10 Pharma partnering workshops covering partnering opportunities in the major therapeutic areas of CNS, immunology, oncology and vaccines, with presentations from Bristol-Myers Squibb, Merck & Co., Merck Serono, Novartis, Nycomed and Roche.
- 500 meeting slots with online 1to-1 meeting system
- Networking Reception on the evening of the 11th Feb
- The 2010 DyoDelta European Life Science Innovation Awards

Speakers & Chairs to date include:

- Genghis Lloyd-Harris, Partner, Abingworth Management Ltd
- Simon Buckingham, President, Global Corporate and Business Development, Actelion Pharmaceuticals
- Anders Hedegaard, President and CEO, Bavarian Nordic
- Markus Hosang, General Partner, BioMedPartners
- Lubor Gaal, Executive Director, Head of Europe, Strategic Transactions Group, Bristol-Myers Squibb
- Stephanie Léouzon, Senior Advisor, Credit Suisse
- Wolfgang Renner, CEO, Cytos Biotechnology AG
- Dimitri Dimitriou, CEO, DyoDelta Biosciences
- Marion Jung, Principal, Earlybird Venture Capital
- Olivier Litzka, Partner, Edmond de Rothschild Investment Partners
- Eric Le Royer, President & CEO, Endosense
- Beth Jacobs, Managing Partner, Excellentia Global Partners
- Nigel Sheail, Head Corporate Business Development, F. Hoffmann-La Roche Ltd.
- Arthur Franken, Partner, Gilde Investment Management.
- Shelagh Wilson, Vice President, Head of European CEEDD, GSK
- Carlton Brown, CEO, Immune Targeting Systems
- Thomas Klaue, CFO, Medigene
- Margaret Beer, Senior Director, Scientific Liaison, Licensing and External Research, Europe, Merck & Co
- Rüdiger Weseloh, Head Negotiation, Early Stage Licensing, Merck Serono
- Roel Bulthius, Head of Merck Serono Ventures, Merck Serono Ventures
- Anthony Hartley, Executive Director, Morgan Stanley
- David Chiswell, CEO, Nabriva Therapeutics AG
- Denise Pollard-Knight, Managing Director, Nomura Phase4 Ventures
- Esteban Pombo Villar, Head of Strategic Alliance Management EU, Novartis Pharma
- Knut Sturmhoefel, Head Alliance Management, Global Business Development & Licensing, Novartis Pharma
- Markus Goebel, Managing Director, Novartis Venture Funds
- Ulrik Spork, Managing Partner, Novo Growth Equity
- Carlos de Sousa, Vice-President Licensing, Business Development, Nycomed
- Peter Honig, Managing Director, PH Regulatory Medical Advisors
- Alex Chanas, Senior Director, Worldwide Licensing and Business Development, Pfizer Inc.
- Fintan Walton, CEO, PharmaVentures Ltd
- Paul Leijten, Senior Partnering Director, Teva Pharmaceuticals Europe
- Alexandra Goll, Partner, TVM Capital
- Ken Cunningham, CEO, SkyePharma Plc
- Antoine Papiernik, Managing Partner, Sofinnova Partners
- Simon Turton, Managing Director Healthcare, Warburg Pincus LLC
- Peter Llewellyn-Davies, CFO, Wilex AG

Sign up as a presenting company now to avoid disappointment! Presenting places are limited and the package includes:

- A 15 minute presentation slot
- 2 complimentary guest passes including staff
- Access to our online 121 meeting system with publication of your profile
- Access to all workshops, presentations and panel discussions
- A full-page company profile in the conference guide
- Company listing on the event website
- Distribution of company marketing material at the conference
- Networking lunches, coffee breaks and dinner during the conference